Company intelligence / Profile preview

Intermedt Medizin & Technik

Ostrhauderfehn, Germany

Ownership: Private
Employees: ~22
Development stage: Other

Overview

Intermedt develops fully automated systems for preparing dialysis concentrates used in hemodialysis treatment. The company's ECOMix-Revolution system, launched in 2016, enables dialysis centers to prepare acid concentrates in a simple, flexible, and environmentally friendly manner with reduced transport emissions and plastic waste.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

B. Braun Avitum

Beyond the preview

Go deeper on Intermedt Medizin & Technik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intermedt Medizin & Technik.

Explore the full profile